Regeneron：我不擔心 ROIC 與營業利益率的回落 (NASDAQ:REGN)
· seekingalpha.com
Regeneron Pharmaceuticals, Inc. 買進評等：Dupixent 與 Libtayo 帶動成長，抵銷波動與 Eylea 生物相似藥風險；利潤率有望回升。點擊查看 REGN 最新更新。
Regeneron Pharmaceuticals, Inc. ( REGN ), based in Tarrytown, NJ, is a leading biotechnology company with a fantastic track-record of rewarding shareholders ove...